Efficacy and safety of artesunate–amodiaquine and artemether–lumefantrine and prevalence of molecular markers associated with resistance, Guinea: an open-label two-arm randomised controlled trial

被引：0
|
作者：
Abdoul Habib Beavogui
Alioune Camara
Alexandre Delamou
Mamadou Saliou Diallo
Abdoulaye Doumbouya
Karifa Kourouma
Patrice Bouedouno
Timothée Guilavogui
Samaly dos Santos Souza
Julia Kelley
Eldin Talundzic
Aissata Fofana
Mateusz M. Plucinski
机构：
[1] Centre National de Formation et de Recherche en Santé Rurale de Maferinyah,Department of Medical Sciences
[2] Gamal Abdel Nasser University,Centre d’Excellence Africain pour la Prévention et le Contrôle des Maladies Transmissibles (CEA
[3] Gamal Abdel Nasser University,PCMT)
[4] Gamal Abdel Nasser University,Department of Public Health
[5] National Malaria Control Programme,Malaria Branch
[6] Direction of Epidemiology,Atlanta Research and Education Foundation and Malaria Branch
[7] Ministry of Health,Malaria Branch and U.S. President’s Malaria Initiative
[8] Centers for Disease Control and Prevention,undefined
[9] Centers for Disease Control and Prevention,undefined
[10] RTI International,undefined
[11] Centers for Disease Control and Prevention,undefined
来源：
Malaria Journal | / 19卷
关键词：
Efficacy; Artesunate–amodiaquine; Artemether–lumefantrine; Molecular makers; Guinea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial
    Li, Guoming
    Yuan, Yueming
    Zheng, Shaoqin
    Lu, Chenguang
    Li, Mingqiang
    Tan, Ruixiang
    Zhang, Hongying
    Silai, Rahamatou
    Liu, Ruimei
    Abdallah, Kamal Said
    Bacar, Affane
    Xu, Qin
    Song, Jianping
    Wu, Wanting
    Deng, Changsheng
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (04)
  • [42] Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire
    Offianan A Toure
    Serge B Assi
    Tiacoh L N’Guessan
    Gbessi E Adji
    Aristide B Ako
    Marie J Brou
    Marie F Ehouman
    Laeticia A Gnamien
    M’Lanhoro AA Coulibaly
    Baba Coulibaly
    Sylvain Beourou
    Issiaka Bassinka
    Adama Soumahoro
    Florence Kadjo
    Mea A Tano
    Malaria Journal, 13
  • [43] Correction to: Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
    Chris Ebong
    Asadu Sserwanga
    Jane Frances Namuganga
    James Kapisi
    Arthur Mpimbaza
    Samuel Gonahasa
    Victor Asua
    Sam Gudoi
    Ruth Kigozi
    James Tibenderana
    John Bosco Bwanika
    Agaba Bosco
    Denis Rubahika
    Daniel Kyabayinze
    Jimmy Opigo
    Damian Rutazana
    Gloria Sebikaari
    Kassahun Belay
    Mame Niang
    Eric S. Halsey
    Leah F. Moriarty
    Naomi W. Lucchi
    Samaly S. Svigel Souza
    Sam L. Nsobya
    Moses R. Kamya
    Adoke Yeka
    Malaria Journal, 21
  • [44] Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial
    Birgit Schramm
    Parastou Valeh
    Elisabeth Baudin
    Charles S Mazinda
    Richard Smith
    Loretxu Pinoges
    Mehul Dhorda
    Yap Boum
    Timothy Sundaygar
    Yah M Zolia
    Joel J Jones
    Eric Comte
    Pascal Houzé
    Vincent Jullien
    Gwenaelle Carn
    Jean-René Kiechel
    Elizabeth A Ashley
    Philippe J Guérin
    Malaria Journal, 12
  • [45] Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial
    Li, Guoming
    Yuan, Mei
    Li, Haihong
    Deng, Changsheng
    Wang, Qi
    Tang, Yexiao
    Zhang, Hongying
    Yu, Weisheng
    Xu, Qin
    Zou, Yuanyuan
    Yuan, Yueming
    Guo, Jiawen
    Jin, Chunming
    Guan, Xiangdong
    Xie, Fengjie
    Song, Jianping
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (01)
  • [46] Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial
    Schramm, Birgit
    Valeh, Parastou
    Baudin, Elisabeth
    Mazinda, Charles S.
    Smith, Richard
    Pinoges, Loretxu
    Dhorda, Mehul
    Boum, Yap, II
    Sundaygar, Timothy
    Zolia, Yah M.
    Jones, Joel J.
    Comte, Eric
    Houze, Pascal
    Jullien, Vincent
    Carn, Gwenaelle
    Kiechel, Jean-Rene
    Ashley, Elizabeth A.
    Guerin, Philippe J.
    MALARIA JOURNAL, 2013, 12
  • [47] Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
    de Jong, Evelien
    van Oers, Jos A.
    Beishuizen, Albertus
    Vos, Piet
    Vermeijden, Wytze J.
    Haas, Lenneke E.
    Loef, Bert G.
    Dormans, Tom
    van Melsen, Gertrude C.
    Kluiters, Yvette C.
    Kemperman, Hans
    van den Elsen, Maarten J.
    Schouten, Jeroen A.
    Streefkerk, Joern O.
    Krabbe, Hans G.
    Kieft, Hans
    Kluge, Georg H.
    van Dam, Veerle C.
    van Pelt, Joost
    Bormans, Laura
    Otten, Martine Bokelman
    Reidinga, Auke C.
    Endeman, Henrik
    Twisk, Jos W.
    van de Garde, Ewoudt M. W.
    de Smet, Anne Marie G. A.
    Kesecioglu, Jozef
    Girbes, Armand R.
    Nijsten, Maarten W.
    de lange, Dylan W.
    LANCET INFECTIOUS DISEASES, 2016, 16 (07): : 819 - 827
  • [48] EFFICACY AND SAFETY OF THE PATIENT EMPOWERMENT THROUGH PREDICTIVE PERSONALISED DECISION SUPPORT (PEPPER) SYSTEM: AN OPEN-LABEL RANDOMISED CONTROLLED TRIAL
    Avari, P.
    Leal, Y.
    Wos, M.
    Jugnee, N.
    Thomas, M.
    Massana, J.
    Lopez, B.
    Nita, L.
    Martin, C.
    Herrero, P.
    Oliver, N.
    Fernandez-Real, J.
    Reddy, M.
    Fernandez-Balsells, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A104 - A104
  • [49] Artemether-lumefantrine-amodiaquine or artesunate- amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised controlled trial
    Mahamar, Almahamoudou
    Vanheer, Leen N.
    Smit, Merel J.
    Sanogo, Koualy
    Sinaba, Youssouf
    Niambele, Sidi M.
    Diallo, Makonon
    Dicko, Oumar M.
    Diarra, Richard S.
    Maguiraga, Seydina
    Youssouf, Ahamadou
    Sacko, Adama
    Keita, Sekouba
    Samake, Siaka
    Dembele, Adama
    Teelen, Karina
    Dicko, Yahia
    Traore, Sekou F.
    Dondorp, Arjen
    Drakeley, Chris
    Stone, William
    Dicko, Alassane
    LANCET MICROBE, 2025, 6 (02):
  • [50] Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: A single-arm, open-label clinical trial
    Takazono, Takahiro
    Hosogaya, Naoki
    Fukushima, Koki
    Morio, Ryosuke
    Irifune, Satoshi
    Miyamura, Takuto
    Harada, Yosuke
    Nagayoshi, Yosuke
    Kondo, Akira
    Mihara, Tomo
    Fukuda, Yuichi
    Sasaki, Eisuke
    Sawai, Toyomitsu
    Imamura, Yoshifumi
    Morikawa, Toru
    Futsuki, Yoji
    Inoue, Yuichi
    Fukushima, Kiyoyasu
    Suyama, Naofumi
    Tanaka, Hikaru
    Hanaka, Tetsuya
    Shimabukuro, Ikuko
    Hata, Ryosuke
    Ota, Kenji
    Morimoto, Shimpei
    Nakada, Nana
    Ito, Yuya
    Yoshida, Masataka
    Takeda, Kazuaki
    Ide, Shotaro
    Iwanaga, Naoki
    Nemoto, Kazuki
    Funada, Midori
    Izumikawa, Koichi
    Yatera, Kazuhiro
    Yanagihara, Katsunori
    Mukae, Hiroshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (07) : 597 - 602
12345